$591.17
-2.14-0.36%
At close: Nov 13, 4:00 PM EST
$591.17
N/A
After Hours: Nov 13, 5:44 PM EST
United Therapeutics Corp
UTHRNASDAQ
United Therapeutics (UTHR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $5.71 | $6.00 | -4.83 % |
| Q2 | Aug 5, 2026 | $7.27 | $6.86 | 5.98 % |
| Q1 | May 6, 2026 | $5.82 | $6.83 | -14.8 % |
| Q4 | Feb 25, 2026 | $7.70 | $6.77 | 13.7 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $832.50M | $781.58M | 6.52 % |
| Q2 | Aug 5, 2026 | $783.30M | $807.00M | -2.94 % |
| Q1 | May 6, 2026 | $781.50M | $797.97M | -2.06 % |
| Q4 | Feb 25, 2026 | $790.20M | $808.93M | -2.32 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.00 | $6.86 | $6.83 | $6.77 |
| Actual | $5.71 | $7.27 | $5.82 | $7.70 |
| Surprise | -4.83% | +5.98% | -14.8% | +13.7% |
| Revenue | ||||
| Estimate | $781.6M | $807.0M | $798.0M | $808.9M |
| Actual | $832.5M | $783.3M | $781.5M | $790.2M |
| Surprise | +6.52% | -2.94% | -2.06% | -2.32% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $5.38 | $6.72 | $6.10 | $8.03 |
| Revenue | ||||
| Consensus | $853.5M | $795.8M | — | — |
